Wird geladen...
A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer
Metastatic castration resistant prostate cancer (mCRPC) is one of the most common cancers with a poor prognosis. To improve prognostic models of mCRPC, the Dialogue for Reverse Engineering Assessments and Methods (DREAM) Consortium organized a crowdsourced competition known as the Prostate Cancer DR...
Gespeichert in:
| Veröffentlicht in: | F1000Res |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
F1000 Research Limited
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6556990/ https://ncbi.nlm.nih.gov/pubmed/31231503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8192.2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|